News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Intellectual property
Policy
Opinion: Think Beyond the Utility Patent to Protect Your Portfolio
Design patents, trademarks, copyright and trade secrets offer lower cost, and sometimes underappreciated, forms of intellectual property.
February 6, 2024
·
6 min read
·
April Wurster, Jaime Choi, Christopher Franich and David Nigro
PRESS RELEASES
Press Releases
Xeris Announces Orange Book Listing of U.S. Patent for Recorlev®
August 25, 2025
·
7 min read
Press Releases
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
August 21, 2025
·
4 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
August 21, 2025
·
5 min read
Press Releases
Merakris Therapeutics Receives USPTO Notice of Allowance for Foundational Patent Supporting MTX-001 Biologic Drug Platform
August 20, 2025
·
4 min read
Press Releases
Selonterra announces grant of United States patent on original discoveries in Alzheimer’s disease
August 19, 2025
·
1 min read
Press Releases
scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
August 15, 2025
·
4 min read
Press Releases
BioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D™ Fusion Imaging for Interventional Cardiology
August 14, 2025
·
5 min read
Press Releases
USPTO Grants Key Mechanism of Action Patent to Bonum Therapeutics for its Conditionally Active Biologics Technology
August 14, 2025
·
3 min read
Press Releases
Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 14, 2025
·
9 min read
Press Releases
ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
August 13, 2025
·
5 min read
Press Releases
ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
August 13, 2025
·
17 min read
Press Releases
Xspray Pharma Signs License Agreement with Handa Therapeutics – to Receive up to Double-Digit Royalty on Handa’s Net Proceeds
August 12, 2025
·
1 min read
Press Releases
BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
August 12, 2025
·
12 min read
Press Releases
Sitryx regains rights to SYX-1042 itaconate mimetic for chronic autoimmune and inflammatory diseases from Lilly following portfolio reprioritization
August 11, 2025
·
2 min read
Press Releases
Annovis Completes Full Patent Transfer to Crystal Buntanetap
August 8, 2025
·
4 min read
Press Releases
Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038
August 6, 2025
·
6 min read
Press Releases
Palisade Bio Receives Notice of Allowance for Composition of Matter Patent Covering Lead Product Candidate PALI-2108 in China
August 1, 2025
·
4 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology
July 31, 2025
·
5 min read
Press Releases
Zetagen Therapeutics Secures Composition-of-Matter Patents from USPTO for Novel Breast Cancer Platform
July 29, 2025
·
5 min read
Press Releases
Arrowhead Pharmaceuticals Issues Statement on the Status of its Ongoing Agreement with Sarepta Therapeutics
July 24, 2025
·
6 min read
